From GlobeNewswire:

Kiniksa Pharmaceuticals, Ltd. will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024 at 1:30 p.m. Pacific Time. A live webcast of the presentation will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. Kiniksa is a biopharmaceutical company focused on discovering and commercializing therapeutic medicines for patients with significant unmet medical needs.

The company’s immune-modulating assets, ARCALYST, KPL-404, and mavrilimumab, target underserved cardiovascular and autoimmune conditions and offer the potential for differentiation. ARCALYST® is a registered trademark of Regeneron Pharmaceuticals, Inc. For more information, visit www.kiniksa.com. A replay of the webcast will be available on Kiniksa’s website within approximately 48 hours after the event.



Read more: Kiniksa Pharmaceuticals to Present at 42nd Annual J.P.